Thomas Ebeling Cullinan Oncology, Inc. (CGEM) insider trading activity

CGEM Quotes by TradingView

Thomas Ebeling is of Cullinan Oncology, Inc.. Currently has a direct ownership of 186,653 shares of CGEM, which is worth approximately $2.29 Million. The most recent transaction as insider was on Jun 10, 2024, when has been sold 18,450 shares (Common Stock) at a price of $13.0 per share, resulting in proceeds of $239,850. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 187K
0% 3M change
n/a 12M change
Total Value Held $2.29 Million

Thomas Ebeling Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 10 2024
BUY
Exercise of conversion of derivative security
$239,850 $13.0 p/Share
18,450 Added 9.0%
186,653 Common Stock
May 23 2024
BUY
Grant, award, or other acquisition
$857,955 $8.52 p/Share
100,699 Added 37.45%
168,203 Common Stock
TE

Thomas Ebeling

Cambridge, MA

Track Institutional and Insider Activities on CGEM

Follow Cullinan Oncology, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CGEM shares.

Notify only if

Insider Trading

Get notified when an Cullinan Oncology, Inc. insider buys or sells CGEM shares.

Notify only if

News

Receive news related to Cullinan Oncology, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CGEM